Evidence map›Paper›PMID 35488064›Full record

ArticleHuman genetics2022

Genetic genealogy uncovers a founder deletion mutation in the cerebral cavernous malformations 2 gene.

Carol J Gallione, Matthew R Detter, Adrienne Sheline, Henrietta M Christmas, Cornelia Lee, Douglas A Marchuk

Open access · greenAbstract read
In one paragraph

Article in Human genetics, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.

0numbers the graph read from it
0cells of the map it votes in
3citing papers in PubMed
0.4field-weighted citation impact, top 40% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

3 citing papers in PubMed, 3 citations in OpenAlex.

  1. Review
  2. Article
  3. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors at 2 institutions in 1 country.

Carol J GallioneDepartment of Molecular Genetics and Microbiology, Duke University School of Medicine, Durham, NC, 27710, USA.
Matthew R DetterDepartment of Molecular Genetics and Microbiology, Duke University School of Medicine, Durham, NC, 27710, USA.
Adrienne ShelineAngioma Alliance, Charlottesville, VA, 22901, USA.
Henrietta M ChristmasAngioma Alliance, Charlottesville, VA, 22901, USA.
Cornelia LeeAngioma Alliance, Charlottesville, VA, 22901, USA.
Douglas A MarchukDepartment of Molecular Genetics and Microbiology, Duke University School of Medicine, Durham, NC, 27710, USA. douglas.marchuk@duke.edu.ORCID http://orcid.org/0000-0002-3110-6671
Angioma Alliance · USDuke University · US

Funding

Somatic mutation(s) and cellular changes in CCM pathogenesisP01NS092521 · NINDS · DUKE UNIVERSITY · PI MARCHUK, DOUGLAS A. · 2015 to 2024
$12.9M
Foundation for the National Institutes of Health P01-NS092521NINDS NIH HHS P01 NS092521
6 · The paper itself

Abstract

Cerebral cavernous malformations (CCM) are vascular malformations consisting of collections of enlarged capillaries occurring in the brain or spinal cord. These vascular malformations can occur sporadically or susceptibility to develop these can be inherited as an autosomal dominant trait due to mutation in one of three genes. Over a decade ago, we described a 77.6 Kb germline deletion spanning exons 2-10 in the CCM2 gene found in multiple affected individuals from seemingly unrelated families. Segregation analysis using linked, microsatellite markers indicated that this deletion may have arisen at least twice independently. In the ensuing decades, many more CCM patients have been identified with this deletion. In this present study we examined 27 reportedly unrelated affected individuals with this deletion. To investigate the origin of the deletion at base pair level resolution, we sequenced approximately 10 Kb upstream and downstream from the recombination junction on the deleted allele. All patients showed the identical SNP haplotype across this combined 20 Kb interval. In parallel, genealogical records have traced 11 of these individuals to five separate pedigrees dating as far back as the 1600-1700s. These haplotype and genealogical data suggest that these families and the remaining "unrelated" samples converge on a common ancestor due to a founder mutation occurring centuries ago on the North American continent. We also note that another gene, NACAD, is included in this deletion. Although patient self-reporting does not indicate an apparent phenotypic consequence for heterozygous deletion of NACAD, further investigation is warranted for these patients.

Indexed as

Hemangioma, Cavernous, Central Nervous SystemProto-Oncogene ProteinsCarrier ProteinsHumansIntellectual DisabilityMicrognathismMutationPedigreeRibsSequence DeletionCarrier ProteinsCCM2 protein, humanProto-Oncogene Proteins

Identifiers

PMID35488064
PMCPMC9940658
OpenAlexW4225257406

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.